The invention relates to a
medicine for treating
dry eye syndromes. The
medicine for treating
dry eye syndromes comprises the following components in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of dried ginger, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of
angelica dahurica, 5-15 parts of
inula flower, 10-30 parts of cowherb seed, 1-15 parts of
motherwort fruit, 10-20 parts of radix sileris, 15-30 parts of capillary
artemisia, 20-30 parts of myrobalan, 1-20 parts of fenugreek, 1-20 parts of celandine, 10-25 parts of rhizoma imperatae, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of
semen pharbitidis, 15-20 parts of lychee seed, 15-30 parts of glabrous sarcandra
herb, 10-20 parts of
clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of folium rhododendri daurici, 15-25 parts of
potentilla discolor, 10-20 parts of calyx seu fructus
physalis, 15-25 parts of
white mulberry root-
bark, 20-30 parts of lindley
eupatorium, 1-20 parts of gorgon euryale seed and 10-25 parts of Chinese
azalea flower. All the components of the
medicine for treating
dry eye syndromes are natural materials, so that the medicine for treating the dry eye syndromes has good safety and clear
curative effect and is suitable for large-scale application in clinic.